Onesource Specialty Pharma Ltd May Acquire Sterile Injectable CDMO, CMO Businesses of Steriscience Pte. and Brooks Steriscience Ltd

Onesource Specialty Pharma Ltd has received in-principle approval from its Board of Directors to evaluate the potential acquisition of Sterile Injectable CDMO and CMO businesses of Steriscience Pte. Limited (SteriScience SG) and Brooks Steriscience Limited. The proposed acquisition includes a USFDA-approved sterile fill-finish manufacturing facility in Warsaw, Poland, and a carbapenem facility in Vadodara, India. These facilities are currently owned by the Promoters of the Company. The Board has authorized the Management to undertake detailed evaluation of the potential transaction, including suggesting an optimal structure, and to appoint Consultants, Advisors, Valuers, Merchant Bankers, and other intermediaries as required. The Company will make appropriate disclosures in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable laws.